JP2012514994A - 非コードrna発現アッセイを用いた方法 - Google Patents

非コードrna発現アッセイを用いた方法 Download PDF

Info

Publication number
JP2012514994A
JP2012514994A JP2011545794A JP2011545794A JP2012514994A JP 2012514994 A JP2012514994 A JP 2012514994A JP 2011545794 A JP2011545794 A JP 2011545794A JP 2011545794 A JP2011545794 A JP 2011545794A JP 2012514994 A JP2012514994 A JP 2012514994A
Authority
JP
Japan
Prior art keywords
expression
coding rna
intervention
interventions
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011545794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514994A5 (enExample
Inventor
エスティベイロ,ジャシント・ピーター
ゴードン,ジョン・フランシス
ヒリアー,クリストファー・ロバート
オブライエン,ビンセント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sistemic Scotland Ltd
Original Assignee
Sistemic Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0900809A external-priority patent/GB0900809D0/en
Priority claimed from GB0917708A external-priority patent/GB0917708D0/en
Application filed by Sistemic Scotland Ltd filed Critical Sistemic Scotland Ltd
Publication of JP2012514994A publication Critical patent/JP2012514994A/ja
Publication of JP2012514994A5 publication Critical patent/JP2012514994A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/142Toxicological screening, e.g. expression profiles which identify toxicity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2011545794A 2009-01-19 2010-01-19 非コードrna発現アッセイを用いた方法 Pending JP2012514994A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0900809.5 2009-01-19
GB0900809A GB0900809D0 (en) 2009-01-19 2009-01-19 Methods employing non-coding RNA expression assays
GB0917708.0 2009-10-09
GB0917708A GB0917708D0 (en) 2009-10-09 2009-10-09 Methods employing non-coding rna expression assays
PCT/GB2010/000076 WO2010082039A1 (en) 2009-01-19 2010-01-19 Methods employing non-coding rna expression assays

Publications (2)

Publication Number Publication Date
JP2012514994A true JP2012514994A (ja) 2012-07-05
JP2012514994A5 JP2012514994A5 (enExample) 2013-03-07

Family

ID=42078007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011545794A Pending JP2012514994A (ja) 2009-01-19 2010-01-19 非コードrna発現アッセイを用いた方法

Country Status (10)

Country Link
US (3) US9074241B2 (enExample)
EP (2) EP2387617B1 (enExample)
JP (1) JP2012514994A (enExample)
KR (1) KR20110138341A (enExample)
CN (1) CN102356163A (enExample)
AU (1) AU2010205493A1 (enExample)
CA (1) CA2787218A1 (enExample)
IL (1) IL214154A (enExample)
SG (2) SG196843A1 (enExample)
WO (1) WO2010082039A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014049D0 (en) * 2010-08-23 2010-10-06 Sistemic Uk Cell characterisation
CN108319814B (zh) * 2018-01-29 2018-12-14 中国科学院生物物理研究所 基于染色体空间相互作用预测长非编码rna生物学功能的方法
CN111899788B (zh) * 2020-07-06 2023-08-18 李霞 一种非编码rna调控疾病风险靶通路的识别方法及系统
CN113593700B (zh) * 2021-08-06 2024-02-27 江苏师范大学 分析肺癌进展的方法、装置、设备、介质及程序产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002528095A (ja) * 1998-10-27 2002-09-03 ロゼッタ・インファーマティクス・インコーポレーテッド 同時調節された遺伝子セットを使用して遺伝子発現パターンの検出および分類を向上させる方法
JP2007532100A (ja) * 2004-04-07 2007-11-15 エクシコン・アクティーゼルスカブ microRNAおよび低分子干渉RNAの定量化のための新規方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056761A2 (en) * 2003-12-05 2005-06-23 Massachusetts Institute Of Technology REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
US20100310583A1 (en) 2007-01-31 2010-12-09 Immune Disease Institute Let-7 microrna and mimetics thereof as therapeutics for cancer
CA2678919A1 (en) 2007-03-27 2008-10-02 Ranit Aharonov Gene expression signature for classification of cancers
WO2008154098A2 (en) * 2007-06-07 2008-12-18 Wisconsin Alumni Research Foundation Reagents and methods for mirna expression analysis and identification of cancer biomarkers
US8367318B2 (en) * 2007-07-23 2013-02-05 Dharmacon, Inc. Screening of micro-RNA cluster inhibitor pools
CA2676113C (en) * 2007-07-25 2014-07-08 University Of Louisville Research Foundation, Inc. Exosome-associated microrna as a diagnostic marker
JP2011505143A (ja) * 2007-11-30 2011-02-24 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション マイクロrna発現プロファイリング及び肺癌における末梢血ターゲティング

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002528095A (ja) * 1998-10-27 2002-09-03 ロゼッタ・インファーマティクス・インコーポレーテッド 同時調節された遺伝子セットを使用して遺伝子発現パターンの検出および分類を向上させる方法
JP2007532100A (ja) * 2004-04-07 2007-11-15 エクシコン・アクティーゼルスカブ microRNAおよび低分子干渉RNAの定量化のための新規方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN5012007881; KRUTZFELDT J: 'SILENCING OF MICRORNAS IN VIVO WITH ANTAGOMIRS' NATURE , 20051201, P685-689, NATURE PUBLISHING GROUP *
JPN5012007882; MOSCHOS STERGHIOS A: 'EXPRESSION PROFILING IN VIVO DEMONSTRATES RAPID CHANGES IN LUNG MICRORNA LEVELS 以下備考' BMC GENOMICS V8, 200707 *
JPN6014028405; RNA, 2008 [Available online 2008.03.20], Vol. 14, No. 5, pp. 836-843 *
JPN6014028408; Cancer Cell, 2006, Vol. 9, No. 6, pp. 435-443 *
JPN6014028411; J. Cell. Mol. Med., 2008, Vol. 12, No. 1, pp. 227-240 *

Also Published As

Publication number Publication date
WO2010082039A1 (en) 2010-07-22
EP2492357A1 (en) 2012-08-29
US20110312524A1 (en) 2011-12-22
KR20110138341A (ko) 2011-12-27
US20160002722A1 (en) 2016-01-07
US20170058346A1 (en) 2017-03-02
EP2492357B1 (en) 2015-09-23
IL214154A0 (en) 2011-08-31
SG196843A1 (en) 2014-02-13
EP2387617B1 (en) 2014-10-29
EP2387617A1 (en) 2011-11-23
CN102356163A (zh) 2012-02-15
IL214154A (en) 2016-10-31
CA2787218A1 (en) 2010-07-22
SG173042A1 (en) 2011-08-29
AU2010205493A1 (en) 2011-09-08
US9074241B2 (en) 2015-07-07

Similar Documents

Publication Publication Date Title
Saldi et al. Alternative RNA structures formed during transcription depend on elongation rate and modify RNA processing
Krebs et al. Genome-wide single-molecule footprinting reveals high RNA polymerase II turnover at paused promoters
Militello et al. Screening and validation of lncRNAs and circRNAs as miRNA sponges
Aw et al. In vivo mapping of eukaryotic RNA interactomes reveals principles of higher-order organization and regulation
Hulke et al. Genomic methods for measuring DNA replication dynamics
Chu et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions
Courts et al. Specific micro‐RNA signatures for the detection of saliva and blood in forensic body‐fluid identification
US9617581B2 (en) Methods for in vivo identification of endogenous mRNA targets of MicroRNAs
Nicholson et al. Quantifying RNA binding sites transcriptome-wide using DO-RIP-seq
CN104093859A (zh) 多基因生物标志物的鉴定
Rajan et al. Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation
US20170058346A1 (en) Methods Employing Non-Coding RNA Expression Assays
Luo et al. Exploring CircRNA N6-methyladenosine in human rheumatoid arthritis: Hyper-methylated hsa_circ_0007259 as a potential biomarker and its involvement in the hsa_circ_0007259/hsa_miR-21-5p/STAT3 axis
Mastoridis et al. Emergent transcriptomic technologies and their role in the discovery of biomarkers of liver transplant tolerance
Assis et al. What is the transcriptome and how it is evaluated
Decruyenaere et al. Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
Nadukkandy et al. Clinical application of single‐cell RNA sequencing in disease and therapy
CN104774914B (zh) 胆道闭锁及淤胆型婴儿肝炎综合征的microRNA血清标志物检测及其应用
Rossin et al. Single-cell RNA sequencing: An overview for the ophthalmologist
Li et al. MicroRNAome of splenic macrophages in hypersplenism due to portal hypertension in hepatitis B virus-related cirrhosis
Sarkar et al. MicroRNA mediated gene regulatory circuits leads to machine learning based preliminary detection of acute myeloid leukemia
Rahman et al. From compartments to gene loops: Functions of the 3D genome in the human brain
Bhawe et al. Microarray analysis in glioblastomas
Wang et al. Genome-wide RNA structure changes during human neurogenesis drive gene regulatory networks
Dogan et al. Structural Analysis of microRNAs in Myeloid Cancer Reveals Consensus Motifs. Genes 2022, 13, 1152

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130118

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141007

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141015

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141107

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141114

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141205

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150602